NCT02775565View on ClinicalTrials.gov

Initial Experience With the AngioVac Venous Drainage Cannula

CompletedOBSERVATIONAL

Enrollment

51

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

May 31, 2017

Conditions

Heart Disease

Interventions

DEVICE

AngioVac

Trial Locations (5)

29425

MUSC, Charleston

58122

Sanford Research, Fargo

90024

UCLA, Los Angeles

91505

Providence St. Joseph, Burbank

98122

Swedish Health Services, Seattle

Sponsors

Lead Sponsor

Angiodynamics, Inc.

All Listed Sponsors

lead

Angiodynamics, Inc.

INDUSTRY

NCT02775565 - Initial Experience With the AngioVac Venous Drainage Cannula | Biotech Hunter | Biotech Hunter